Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yehuda Handelsman

Showing results (61-70 of 157) with videos related to

Pageof 16
Sort By:
Journal of Clinical Lipidology|May 4, 2017
JCL roundtable: Future of the lipid laboratory: Choosing valuable measures among the lipoproteins (part 1)William Virgil Brown, Yehuda Handelsman, Seth S Martin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 11, 2012
American Association of Clinical Endocrinologists' position statement on clinical nutrition and health promotion in endocrinologyM Molly McMahon, Daniel L Hurley, Jeffrey I Mechanick, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes MellitusLiana K Billings, Yehuda Handelsman, Michael Heile, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 11, 2012
American Association of Clinical Endocrinologists' position statement on obesity and obesity medicineJeffrey I Mechanick, Alan J Garber, Yehuda Handelsman, et al.
Journal of Clinical Lipidology|February 1, 2025
Lipid-lowering efficacy of obicetrapib: A comprehensive systematic review and meta-analysisWalter Masson, Leandro Barbagelata, Martin Lobo, et al.
Postgraduate Medicine|September 24, 2016
Lorcaserin treatment allows for decreased number needed to treat for weight and glycemic parameters in week 12 responders with ≥5% weight lossYehuda Handelsman, Randi Fain, Zhixiao Wang, et al.
Postgraduate Medicine|August 24, 2012
Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetesJulio Rosenstock, Eric Hernandez-Triana, Yehuda Handelsman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 15, 2019
DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENTJeffrey I Mechanick, Alan J Garber, George Grunberger, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic ImplicationsMichael Heile, Kathleen Wyne, Liana K Billings, et al.
Diabetes Care|June 22, 2026
Comment on Nieman and Muniyappa Unmasking Hypercortisolism in Difficult-to-Control Type 2 Diabetes: A Useful Paradigm Shift?Yehuda Handelsman, Vivian Fonseca, John B Buse, et al.
Pageof 16

Showing results (61-70 of 157) with videos related to

Sort By:
Pageof 16
Journal of Clinical Lipidology|May 4, 2017
JCL roundtable: Future of the lipid laboratory: Choosing valuable measures among the lipoproteins (part 1)William Virgil Brown, Yehuda Handelsman, Seth S Martin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 11, 2012
American Association of Clinical Endocrinologists' position statement on clinical nutrition and health promotion in endocrinologyM Molly McMahon, Daniel L Hurley, Jeffrey I Mechanick, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes MellitusLiana K Billings, Yehuda Handelsman, Michael Heile, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 11, 2012
American Association of Clinical Endocrinologists' position statement on obesity and obesity medicineJeffrey I Mechanick, Alan J Garber, Yehuda Handelsman, et al.
Journal of Clinical Lipidology|February 1, 2025
Lipid-lowering efficacy of obicetrapib: A comprehensive systematic review and meta-analysisWalter Masson, Leandro Barbagelata, Martin Lobo, et al.
Postgraduate Medicine|September 24, 2016
Lorcaserin treatment allows for decreased number needed to treat for weight and glycemic parameters in week 12 responders with ≥5% weight lossYehuda Handelsman, Randi Fain, Zhixiao Wang, et al.
Postgraduate Medicine|August 24, 2012
Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetesJulio Rosenstock, Eric Hernandez-Triana, Yehuda Handelsman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 15, 2019
DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENTJeffrey I Mechanick, Alan J Garber, George Grunberger, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic ImplicationsMichael Heile, Kathleen Wyne, Liana K Billings, et al.
Diabetes Care|June 22, 2026
Comment on Nieman and Muniyappa Unmasking Hypercortisolism in Difficult-to-Control Type 2 Diabetes: A Useful Paradigm Shift?Yehuda Handelsman, Vivian Fonseca, John B Buse, et al.
Pageof 16